Bausch + Lomb announced its acquisition of Alden through its parent company, Valeant, in a press release.
“We are excited to bring Alden’s strong heritage of a diverse and extensive portfolio of premium specialty lenses, including the Zenlens, a mini-scleral lens, and the NovaKone lenses for keratoconus, into our vision care business as part of Bausch + Lomb Specialty Vision Products,” Mark McKenna, Bausch + Lomb senior vice president and general manager, contact lenses, said in the release. David Bland, director of custom lens business, will lead Specialty Vision Products under McKenna.
Alden executives, Charley Creighton, CEO, and Tom Shone, president, will remain with Bausch + Lomb as senior consultants to McKenna and aid in developing the finished lens portion of the business, according to the release.
As part of the Specialty Vision Products, Bausch + Lomb will provide substantial investment to expand the training and education programs offered to eye care providers and students, as well as other key programs and initiatives, said the company.